Bone disease after transplantation: osteoporosis and fractures risk

被引:27
作者
Kulak, Carolina A. M. [1 ,2 ]
Borba, Victoria Z. C. [1 ,2 ]
Kulak Junior, Jaime [3 ]
Custodio, Melani Ribeiro [4 ]
机构
[1] Univ Fed Parana UFPR, Hosp Clin, Endocrine Div SEMPR, BR-80030013 Curitiba, PR, Brazil
[2] UFPR, Dept Internal Med, Curitiba, PR, Brazil
[3] UFPR, Dept Obstet & Gynecol, Curitiba, PR, Brazil
[4] Univ Sao Paulo, Dept Internal Med, Div Nephrol, Sao Paulo, Brazil
关键词
Transplantation; bone loss; osteoporosis; fractures; immunosuppressive agents; STEM-CELL TRANSPLANTATION; SUCCESSFUL KIDNEY-TRANSPLANTATION; GROWTH-FACTOR; 23; LIVER-TRANSPLANTATION; MINERAL DENSITY; VITAMIN-D; POSTTRANSPLANTATION OSTEOPOROSIS; CARDIAC TRANSPLANTATION; LUNG TRANSPLANTATION; CYCLOSPORINE-A;
D O I
10.1590/0004-2730000003343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Organ transplantation is the gold standard therapy for several end-stage diseases. Bone loss is a common complication that occurs in transplant recipients. Osteoporosis and fragility fractures are serious complication, mainly in the first year post transplantation. Many factors contribute to the pathogenesis of bone disease following organ transplantation. This review address the mechanisms of bone loss including the contribution of the immunosuppressive agents as well as the specific features to bone loss after kidney, lung, liver, cardiac and bone marrow transplantation. Prevention and management of bone loss in the transplant recipient should be included in their post transplant follow-up in order to prevent fractures.
引用
收藏
页码:484 / 492
页数:9
相关论文
共 55 条
  • [1] KDIGO Clinical Practice Guidelines on Hepatitis C in Chronic Kidney Disease acknowledged by ISN
    Abboud, Omar
    Becker, Gavin
    Bellorin-Font, Ezequiel
    Field, Michael
    Johnson, Richard
    Li, Philip K. T.
    Wanner, Christoph
    [J]. NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (12): : 648 - 649
  • [2] Decrease in Bone Mass in Women After Liver Transplantation: Associated Factors
    Baccaro, L. F.
    Boin, I. F. S. F.
    Pedro, A. O.
    Costa-Paiva, L.
    Leal, A. L. G.
    Ramos, C. D.
    Pinto-Neto, A. M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (04) : 1351 - 1356
  • [3] Reduced parathyroid functional mass after successful kidney transplantation
    Bonarek, H
    Merville, P
    Bonarek, M
    Moreau, K
    Morel, D
    Aparicio, M
    Potaux, L
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (02) : 642 - 649
  • [4] BRYER HP, 1995, J BONE MINER RES, V10, P132
  • [5] Mechanisms of glucocorticoid action in bone
    Canalis, E
    Delany, AM
    [J]. NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS, 2002, 966 : 73 - 81
  • [6] Densitometric Threshold and Vertebral Fractures in Heart Transplant Patients
    Carbonare, Luca Dalle
    Zanatta, Mirko
    Braga, Vania
    Sella, Stefania
    Vilei, Maria Teresa
    Feltrin, Giuseppe
    Gambino, Antonio
    Pepe, Ilenia
    Rossini, Maurizio
    Adami, Silvano
    Giannini, Sandro
    [J]. TRANSPLANTATION, 2011, 92 (01) : 106 - 111
  • [7] Effect of teriparatide on early bone loss after kidney transplantation
    Cejka, D.
    Benesch, T.
    Krestan, C.
    Roschger, P.
    Klaushofer, K.
    Pietschmann, P.
    Haas, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (09) : 1864 - 1870
  • [8] Zoledronic acid prevents bone loss after liver transplantation - A randomized, double-blind, placebo-controlled trial
    Crawford, BAL
    Kam, C
    Pavlovic, J
    Byth, K
    Handelsman, DJ
    Angus, PW
    McCaughan, GW
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (04) : 239 - 248
  • [9] Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation
    D'Souza, A. B.
    Grigg, A. P.
    Szer, J.
    Ebeling, P. R.
    [J]. INTERNAL MEDICINE JOURNAL, 2006, 36 (09) : 600 - 603
  • [10] Dissanayake IR, 1998, TRANSPLANTATION, V65, P275